期刊文献+

重组人脑利钠肽治疗难治性心力衰竭的临床研究

下载PDF
导出
摘要 目的比较重组人脑利钠肽和米力农治疗难治性心力衰竭的疗效及安全性。方法将入选的57例难治性心力衰竭患者按照密封信封抽取法随机分为观察组28例(A组),对照组例29例(B组),在常规纠正心力衰竭治疗基础上分别静脉应用注射用重组人脑利钠肽和米力农,观察并比较两组治疗前后临床状况好转率、心率、尿量、收缩压以及左室射血分数(LVEF)等情况。结果临床状况好转率的比较,观察组显著优于对照组(P<0.05),心率改善及尿量改善等观察组高于对照组(P<0.05)。结论重组人脑利钠肽能明显改善难治性心力衰竭患者的血流动力学,在全身临床状况缓解方面优于米力农,疗效显著,安全性较高。
出处 《中国医药指南》 2011年第14期224-226,共3页 Guide of China Medicine
  • 相关文献

参考文献6

  • 1陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 2Berendes E,Schmidt C,Van Aken H,et al.A-type and B-type natriuretic peptides in cardiac surgical procedures[J].Anesth Analg,2004,98(1): 11-19.
  • 3Swedberg K,Cleland J,Dargie H,et al.Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology[J].Eur Heart J,2005,26(11): 1115-1140.
  • 4Dickstein K, Cohen-Solal A,Filippatos G, et aI.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)[J].Eur Heart J, 2008,10(10):933-989.
  • 5Young JB,Abraham WT, Stevenson LW, et al.Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial[J].JAMA,2002,287(12): 1531-1540.
  • 6Burger AJ,Horton DP, Le Jemtel T, et al.Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely deeompensated congestive heart failure: the PRECEDENT study[J].Am Heart 1,2002,144(6): 1102-1108.

共引文献2784

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部